menu title
State of the ART
-
Presentation Downloads:Related Documents:Related Links:
Presentation Details:
State of the ART:
An Update on Long-Acting Antiretrovirals for HIV Treatment
Presented by:
Brian Wood, MD
Associate Professor, Department of Medicine,
Division of Allergy and Infectious Diseases,
University of Washington
Medical Director,
Mountain West AIDS Education and Training Center (MWAETC) HIV ECHO
Objectives:
Discuss the latest data and controversies regarding long-acting, injectable cabotegravir/rilpivirine.
Highlight recent updates on lenacapavir, a capsid inhibitor likely coming soon as an option for heavily-treatment experienced PWH.
Review the latest findings and plans for the NRTTI islatravir.
State of the ART:
An Update on Long-Acting Antiretrovirals for HIV Treatment
Presented by:
Brian Wood, MD
Associate Professor, Department of Medicine,
Division of Allergy and Infectious Diseases,
University of Washington
Medical Director,
Mountain West AIDS Education and Training Center (MWAETC) HIV ECHO
Objectives:
Discuss the latest data and controversies regarding long-acting, injectable cabotegravir/rilpivirine.
Highlight recent updates on lenacapavir, a capsid inhibitor likely coming soon as an option for heavily-treatment experienced PWH.
Review the latest findings and plans for the NRTTI islatravir.
Presentation Transcript: